Aller au contenu principal
Profil bibliographique

Ewa Kalinka

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
17Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Lung Cancer Research StudiesAdrenal Hormones and DisordersCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesThyroid Disorders and Treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial

Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, Tamar Melkadze et autres

INTRODUCTION: EMPOWER-Lung 3 part 2 trial demonstrated significant survival benefits with cemiplimab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced NSCLC without EGFR, ALK, or ROS1 aberrations. Here, we report 5-year follow-up outcomes. METHODS: Patients were randomized 2:1 to …

ru, pl, us (code pays fourni par la source)

0 citations Journal of Thoracic Oncology
Accès ouvert 2026 conference-abstract OpenAlex

DAREON-8: Updated efficacy and safety from a phase I dose-escalation/expansion trial of first-line (1L) obrixtamig plus chemotherapy and atezolizumab in extensive-stage small cell lung carcinoma (ES-SCLC).

Solange Peters, Rafał Dziadziuszko, Ewa Kalinka, Anas Gazzah et autres

8089 Background: Obrixtamig (BI 764532) is a DLL3/CD3 IgG-like T-cell engager that has shown promising efficacy in ES-SCLC, as monotherapy and in combination with other agents. Due to the aggressiveness of ES-SCLC, early initiation of optimal 1L induction therapy is critical, as …

ch, pl, fr, es, us, cn (code pays fourni par la source)

1 citation Journal of Clinical Oncology
Accès ouvert 2026 article OpenAlex

HPA axis function during adjunctive high-dose dexamethasone use in chemotherapy: a prospective pilot study

Elżbieta Turska, Krzysztof C. Lewandowski, Igor Symonowicz, Magdalena Kobus et autres

Introduction: Glucocorticoid-induced adrenal insufficiency is a well-known adverse effect of glucocorticoid therapy, occurring not only with oral administration but also with intramuscular, inhaled, and other routes of administration. However, the impact of intermittent high-dose glucocorticoids used during chemotherapy on hypothalamic-pituitary-adrenal (HPA) axis …

pl (code pays fourni par la source)

0 citations Frontiers in Endocrinology
Accès ouvert 2026 article OpenAlex

Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial

R. Dent, Rebecca Alexandra Dent, Z. Shao, P. Schmid et autres

BACKGROUND: Prognosis is poor, and treatment options are limited for patients with previously untreated, advanced triple-negative breast cancer (TNBC), especially for those who are not candidates for immunotherapy. PATIENTS AND METHODS: In the randomised, open-label, phase III TROPION-Breast02 trial, patients with previously …

sg, cn, gb, ch, ca, jp, kr, fr, mx, tr, es, Afrique du Sud, tw, hu, it, us, ar, pl, nl (code pays fourni par la source)

16 citations Annals of Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.